MORGAN STANLEY

Holdings History for Applied Therapeutics, Inc. - Common Stock $0.0001 par value per share (APLT)

Symbol: APLT on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock $0.0001 par value per share
Latest Disclosed Ownership: 2.86M shares
Security Ownership: 2.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Applied Therapeutics, Inc. Common Stock $0.0001 par value per share (APLT)

2025-02-07 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.86M shares of Applied Therapeutics, Inc. Common Stock $0.0001 par value per share (APLT). This represents 2.5% percent ownership of the company. In their previous filing dated 2025-02-03, MORGAN STANLEY had reported owning 8.82M shares, indicating a decrease of -67.6% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	2.5%	-63.8%	$1.4M	2.86M	-5,956,595	-67.6%	$0.49	13G/A	1/31/2025	7 Feb 2025 16:13:10
Morgan Stanley	7.6%		$4.31M	8.82M			$0.49	13G/A	12/31/2024	3 Feb 2025 15:30:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	0%	$7.55M	8.82M	-1,088,750	-11%	$0.86	Q4 2024
9/30/2024	0.01%	+0%	$84.2M	9.9M	+6,384,793	+181%	$8.50	Q3 2024
6/30/2024	0%	+0%	$16.4M	3.52M	+325,685	+10.2%	$4.67	Q2 2024
3/31/2024	0%		$21.7M	3.19M			$6.80	Q1 2024
12/31/2023	0%		$180K	53.6K			$3.35	Q4 2023
9/30/2023	0%	0%	$128K	51.4K	-3,353	-6.13%	$2.49	Q3 2023
6/30/2023	0%	+0%	$70K	54.7K	+54,528	+27820%	$1.28	Q2 2023
3/31/2023	0%		$159	196	-4,284	-95.6%	$0.81	Q1 2023
12/31/2022	0%	0%	$3.41K	4.48K	-15,349	-77.4%	$0.76	Q4 2022
9/30/2022	0%	0%	$18K	19.8K	-89,047	-81.8%	$0.91	Q3 2022
6/30/2022	0%	+0%	$103K	109K	+88,752	+441%	$0.95^*	Q2 2022
3/31/2022	0%		$43K	20.1K	+1,341	+7.14%	$2.14^*	Q1 2022
12/31/2021	0%	+0%	$168K	18.8K	+4,202	+28.8%	$8.94^*	Q4 2021
9/30/2021	0%	+0%	$242K	14.6K	+502	+3.57%	$16.60	Q3 2021
6/30/2021	0%		$294K	14.1K	+18	+0.13%	$20.88	Q2 2021
3/31/2021	0%	+0%	$264K	14.1K	+2,483	+21.4%	$18.78	Q1 2021
12/31/2020	0%	+0%	$255K	11.6K	+5,436	+88.5%	$22.02	Q4 2020
9/30/2020	0%	0%	$128K	6.14K	-56,874	-90.3%	$20.84	Q3 2020
6/30/2020	0%	+0%	$2.28M	63K	+59,386	+1636%	$36.15	Q2 2020
3/31/2020	0%	0%	$119K	3.63K	-6,461	-64%	$32.78	Q1 2020
12/31/2019	0%	+0%	$275K	10.1K	+9,576	+1859%	$27.25	Q4 2019
9/30/2019	0%	+0%	$6K	515	+515	NEW	$11.65	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.